Publication date: Aug 01, 2023
Background COVID-19-related pulmonary complications have been explored extensively in the recent past. There is also a significant amount of literature on the neurological manifestations of COVID-19. However, there exists an unmet need to assess the impact of COVID-19 on patients with cerebrovascular diseases and its role in affecting mortality in such patients. Methods In this cross-sectional study, we analyzed 401,318 hospitalized patients with cerebrovascular diseases using the discharge data from the National Inpatient Sample 2020 to assess the association of COVID-19 with multiple clinical conditions, along with additional factors, such as length of stay in the hospital, total charges incurred, region and type of hospital, and primary insurance/payer in the United States of America. We used a multivariable logistic regression model to predict factors relating to mortality in such patients. Results The mortality during hospitalization in patients with cerebrovascular disease who were also diagnosed with COVID-19 was significantly higher than the patients without COVID-19 (22. 50% vs 5. 44%, p-value
| Concepts | Keywords |
|---|---|
| America | cerebrovascular disease |
| Covid | covid-19 |
| Hospitalization | mortality |
| sars-cov-2 |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Cerebrovascular Disease |
| disease | MESH | COVID-19 |
| disease | MESH | complications |